The Signal Journal
Back

Tag

us-markets

Nasdaq Futures Drop 1.1% in Global Tech Sell-Off

Nasdaq futures dropped 1.1% on June 26, 2026, as a global technology sell-off resumed amid concerns over high valuations, production cuts, and rising volatility. S&P 500 futures also slid, pointing to a weak open for US markets with tech-heavy portfolios facing the sharpest pressure.

Nasdaq Recovers as Apple Drops on AI News

U.S. stocks closed mixed, with the Nasdaq posting a partial recovery while the Dow dipped lower. Apple fell after news about its AI plans unsettled investors, weighing on broader market sentiment.

Nasdaq Drops 4% as Fed Rate-Hike Bets Hammer AI Stocks

The Nasdaq dropped 4% on Wednesday as rising bets on Federal Reserve rate hikes hit AI and technology stocks hard. The S&P 500 and Dow Jones also fell, reflecting broad investor concern that borrowing costs could stay higher for longer.

S&P 500, Nasdaq Post Biggest Monthly Gains in Years

The S&P 500 and Nasdaq closed higher Thursday, booking their biggest monthly gains in years as strong corporate earnings offset oil and geopolitical concerns. Alphabet reported a record quarter for its cloud unit, boosting tech sentiment. Industrials and technology sectors led the broad-based rally.

Sun Pharma Buys U.S. Organon in $11.75 Billion Deal

Sun Pharmaceutical Industries has agreed to acquire U.S.-based Organon & Co in an all-cash deal worth $11.75 billion. The deal would be one of the largest overseas acquisitions by an Indian pharma company and expands Sun Pharma's presence in women's health, biosimilars, and branded medicines.

The S&P 500 Rips to New All Time Highs

The S&P 500 has climbed to new all-time highs, marking a fresh peak for the broad U.S. equity benchmark. The move signals positive market sentiment and may influence allocation decisions across institutional and retail portfolios.

← Back

Tag

us-markets

Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal

Sun Pharmaceutical Industries has agreed to acquire U.S.-based Organon & Co in an all-cash deal worth $11.75 billion. The deal would be one of the largest overseas acquisitions by an Indian pharma company and expands Sun Pharma's presence in women's health, biosimilars, and branded medicines.

2mo ago · 1 min · Business

The S&P 500 Rips to New All Time Highs

The S&P 500 has climbed to new all-time highs, marking a fresh peak for the broad U.S. equity benchmark. The move signals positive market sentiment and may influence allocation decisions across institutional and retail portfolios.

2mo ago · 1 min · Markets

— End of feed —